The Nord Tank will compete with fastselling trucks like Toyota Hilux, Mitsubishi L200, Ford Ranger, Leopaard CT7 and INNOSON IVM Carrier 4×4 pickup trucks.
A quick check at the NORD Automobiles website shows that it also manufactures several types of Nigerian branded vehicles.
Nord Automobiles lineups includes the Nord Max, Flit bus, Tank, Aso truck, Lasgi big bus, Q3 sedan, Q5 SUV, Nord Yarn, Ben SUV, Urban sedan and more
According to NORD Automobiles, its operations focus on designs; development; assembling; distribution; marketing and provision of sales and after-sale of premium vehicles at relatively competitive costs.
With this development, Nord Automobiles joins a growing list of Nigerian automotive manufacturer that also includes Innoson Vehicle Manufacturers (IVM); Obasa Specialty Vehicles (OSV); Proforce and Bennie Technologies.
Recent report in Nigeria confirmed that some Scientists in Nigerian universities under the aegis of COVID-19 Research Group yesterday announced the discovery of a vaccine for the prevention of COVID-19.
Addressing a news conference at Adeleke University in Ede, Osun State, Dr Oladipo Kolawole, leader of the team, said the vaccine was being developed locally in Africa for Africans.
Kolawole, a specialist in Medical Virology, Immunology and Bioinformatics at Adeleke University however said the vaccine would also work for other continent when unveiled.
He said the study, which led to the discovery of the vaccine, had enjoyed initial funding by the Trinity Immunodeficient Laboratory and Helix Biogen Consult, Ogbomosho, to the tune of about N7.8 million.
Kolawole said the group had been working extensively by exploring the SARS-CoV-2 genome from African countries to select the best possible potential vaccine candidates.
He said after trying out some selected processes of vaccine development, the researchers had been able to choose the best potential vaccine candidates for the SARS-CoV-2 and had made the possible latent vaccine constructs.
On how soon the unnamed vaccine would be unveiled to the public, Kolawole said that it would take a minimum of 18 months.
According to him, this is because a lot of analysis and studies as well as approvals by medical authorities were still required.